Literature DB >> 3022679

Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype.

S W Barthold, D S Beck, A L Smith.   

Abstract

Mouse hepatitis virus (MHV) S induced typical MHV spongiform lesions in brainstem 28 days following intranasal inoculation of adult A/J, BALB/cByJ, CBA/J, C 3 H/HeJ and C 3 H/RV, but not SJL mice. In all but SJL mice, brain lesions occurred at or near the infectious dose level, based on seroconversion by the indirect immunofluorescence assay. During the acute phase of infection (day 5), lesions were limited to the nose and brain in most genotypes. Exceptions were BALB mice, which had mild hepatitis and SJL mice, which had lesions restricted to the nose. No mortality occurred in any genotype. Following intranasal inoculation of adult mice, MHV-1, -3, -A 59, -JHM and -S all caused brain lesions at 28 days after inoculation. MHV-1 and -3 caused lesions that were usually restricted to the anterior olfactory tracts, while MHV-A 59, -S and -JHM also caused more generalized and pronounced lesions involving the midbrain and pons. These studies suggest that avirulent MHV-S given intranasally to most mouse genotypes is a good model for induction of brain infection in the absence of mortality. They also confirm observations made by others in which MHV-JHM, -S and -A 59 are relatively more neurotropic than other MHV strains, such as MHV-1 and -3.

Entities:  

Mesh:

Year:  1986        PMID: 3022679      PMCID: PMC7087084          DOI: 10.1007/bf01314284

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  35 in total

1.  Pathology of infection with the JHM virus.

Authors:  A M PAPPENHEIMER
Journal:  J Natl Cancer Inst       Date:  1958-05       Impact factor: 13.506

2.  Host and virus factors associated with CNS cellular tropism leading to encephalomyelitis or demyelination induced by the JHM strain of mouse hepatitis virus.

Authors:  R L Knobler; M V Haspel; M Dubois-Dalcq; P W Lampert; M B Oldstone
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

3.  Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients.

Authors:  J S Burks; B L DeVald; L D Jankovsky; J C Gerdes
Journal:  Science       Date:  1980-08-22       Impact factor: 47.728

4.  Experimental demyelination produced by the A59 strain of mouse hepatitis virus.

Authors:  E Lavi; D H Gilden; Z Wroblewska; L B Rorke; S R Weiss
Journal:  Neurology       Date:  1984-05       Impact factor: 9.910

5.  Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination.

Authors:  M V Haspel; P W Lampert; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  Difference in response to mouse hepatitis virus among susceptible mouse strains.

Authors:  F Taguchi; N Hirano; Y Kiuchi; K Fujiwara
Journal:  Jpn J Microbiol       Date:  1976-08

7.  Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation.

Authors:  S W Barthold; A L Smith
Journal:  Lab Anim Sci       Date:  1983-08

8.  Acute and subacute demyelination induced by mouse hepatitis virus strain A59 in C3H mice.

Authors:  J L Woyciechowska; B D Trapp; D H Patrick; I C Shekarchi; P O Leinikki; J L Sever; K V Holmes
Journal:  J Exp Pathol       Date:  1984

9.  Congenic strains of mice susceptible and resistant to mouse hepatitis virus.

Authors:  W Weiser; I Vellisto; F B Bang
Journal:  Proc Soc Exp Biol Med       Date:  1976-09

10.  Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4.

Authors:  R L Knobler; P W Lampert; M B Oldstone
Journal:  Nature       Date:  1982-07-15       Impact factor: 49.962

View more
  16 in total

1.  Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins.

Authors:  R K Williams; G S Jiang; K V Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Virus strain specificity of challenge immunity to coronavirus.

Authors:  S W Barthold; A L Smith
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice.

Authors:  S W Barthold; D S Beck; A L Smith
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Olfactory neural pathway in mouse hepatitis virus nasoencephalitis.

Authors:  S W Barthold
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Spread of a neurotropic murine coronavirus into the CNS via the trigeminal and olfactory nerves.

Authors:  S Perlman; G Jacobsen; A Afifi
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

6.  Duration of challenge immunity to coronavirus JHM in mice.

Authors:  S W Barthold; A L Smith
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities.

Authors:  B D Zelus; D R Wessner; R K Williams; M N Pensiero; F T Phibbs; M deSouza; G S Dveksler; K V Holmes
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection.

Authors:  K Yokomori; M M Lai
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59.

Authors:  G S Dveksler; C W Dieffenbach; C B Cardellichio; K McCuaig; M N Pensiero; G S Jiang; N Beauchemin; K V Holmes
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice.

Authors:  A L Smith; S W Barthold; D S Beck
Journal:  Antiviral Res       Date:  1987-12       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.